Anticipating Teladoc Health's Earnings Release
Teladoc Health (NYSE: TDOC) is on the brink of releasing its quarterly earnings. Investors are keen to discover what this upcoming announcement holds. Analysts predict an earnings per share (EPS) of $-0.24, setting the stage for potential market movements and investor reactions.
Understanding Investor Expectations
Investors are not only looking for earnings performance but also attentive to the guidance for the upcoming quarter. It's crucial for those new to the investing landscape to grasp that guidance often holds significant weight in influencing market sentiment.
Earnings Performance Review
In the previous quarter, Teladoc Health exceeded EPS estimates by $0.10. Despite this positive news, the share price dropped by 1.73% the following day, showcasing the unpredictable nature of market reactions.
Stock Performance Analysis
As of the end of October, Teladoc Health shares were trading at $9.01. Over the past 52 weeks, shares have declined by 5.64%, leading to concerns among long-term investors as they approach the earnings release.
Market Sentiment on Teladoc Health
Understanding the sentiments within the market is essential for investors. Current ratings for Teladoc Health indicate a consensus of Neutral, with analysts issuing two ratings. The average price target for the stock stands at $9.75, indicating a potential 8.21% upward movement.
Competitor Comparison and Market Position
In this section, we compare Teladoc Health with notable competitors, providing insights into their positioning and performance within the healthcare market.
Current Analyst Ratings
Recent evaluations show:
- Phreesia: Outperform, with an average price target of $34.44 reflecting a potential 282.24% upside.
- GoodRx Holdings: Neutral, with a price target of $4.25 suggesting a possible 52.83% downside.
- Schrodinger: Neutral, predicting a price target of $22.20 and potential upside of 146.39%.
Key Insights from Peer Analysis
Within the analysis of peer companies, we observe several vital metrics:
| Company | Consensus | Revenue Growth | Gross Profit | Return on Equity |
|---|---|---|---|---|
| Teladoc Health | Neutral | -1.64% | $441.36M | -2.29% |
| Phreesia | Outperform | 14.83% | $79.61M | 0.23% |
| GoodRx Holdings | Neutral | 1.23% | $189.72M | 1.98% |
| Schrodinger | Neutral | 15.69% | $26.16M | -12.05% |
The Evolution of Teladoc Health
Teladoc Health Inc is a pioneer in virtual healthcare, redefining how patients interact with healthcare services. The company's mission is to support individuals in leading healthier lives through enhanced healthcare experiences. Teladoc operates mainly in two segments: Health Integrated Care and BetterHelp, generating revenue primarily through subscription-based access fees.
Understanding Teladoc Health's Financial Status
Financial Overview: Teladoc currently operates below industry averages, reflecting a smaller scale in comparison to its peers.
Revenue Trend: The company's financials show an approximate decline of -1.64% in revenue growth over the last three months, posing challenges as it competes within the healthcare sector.
Net Margins: Teladoc's net margin is reported at -5.17%, indicating the need for efficient financial management.
ROE and ROA: The company's Return on Equity (ROE) and Return on Assets (ROA) are -2.29% and -1.03%, respectively, illustrating effective capital usage but raising concerns over financial health.
Debt Ratio: Notably, Teladoc's debt-to-equity ratio is higher than the industry average at 0.73, signaling reliance on external financing.
Frequently Asked Questions
What is Teladoc Health's EPS estimate for the upcoming earnings report?
The EPS estimate is $-0.24.
How has Teladoc's stock performed over the past year?
Shares have declined by approximately 5.64% over the last 52 weeks.
What is the current consensus rating for Teladoc Health?
Analysts have given Teladoc a consensus rating of Neutral.
What are the average price targets for Teladoc and its competitors?
The average price target for Teladoc is $9.75, while for Phreesia, it's $34.44, GoodRx $4.25, and Schrodinger $22.20.
What segments does Teladoc Health operate in?
Teladoc operates in Health Integrated Care and BetterHelp segments.
